Leading pharmaceutical firms seek risk-averse management

Published: 2009-01-07 07:00:00

Updated: 2009-01-07 07:00:00

Major Korean drugmakers – Dong-A Pharmaceutical and Yuhan Corporation - are expected to become more conservative this year in the wake of ever-increasing bankruptcies in the wholesaling sector, strengthening risk management and reduce possible losses, according to market sources.

These compani...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK